UnknownNot Applicable

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Italy20 participantsStarted 2023-10-31

Plain-language summary

The aim of this study is to collect sebaceous carcinomas from the Fondazione Policlinico Gemelli retrospectively and prospectively, to analyse them morphologically and immunopathologically and to correlate them with molecular genetic aspects. This study will help to clarify and develop a more effective multidisciplinary diagnostic-therapeutic pathway.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older; * Diagnosis of sebaceous Ca of the ocular adnexa * Ability to obtain formalin-fixed and paraffin-embedded primary and/or metastatic tumour tissue (FFPE) and healthy tissue * Availability of primary and/or metastatic tumour tissue in paraffin-embedded or OCT (prospective part) and healthy tissue * Written informed consent for use of data for research purposes. Exclusion Criteria: * Age \< 18 years; * Lack of sufficient clinical data on selected patients. * Lack of tumor and/or metastatic tissue in kerosene or OCT. * Refusal to give informed consent to data processing for research purposes.

What they're measuring

Concentration of different molecules in Microscopic and immunophenotypic analysis

Timeframe: 1 year

Trial details

NCT IDNCT06080009

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-06

View on ClinicalTrials.gov More Sebaceous Cell Tumor of Eyelid trials